Chinese Vice Premier Proposes Major Disease Coverage; EDL Expansion Could Come Soon
This article was originally published in PharmAsia News
After allowing private insurers to offer services for the public health insurance scheme, the government could also tap them to cover major diseases, says Chinese Vice Premier Li Keqiang.
You may also be interested in...
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.